Literature DB >> 22054058

Synthesis of monomeric derivatives to probe memoquin's bivalent interactions.

Maria Laura Bolognesi1, GianPaolo Chiriano, Manuela Bartolini, Francesca Mancini, Giovanni Bottegoni, Valentina Maestri, Stefan Czvitkovich, Manfred Windisch, Andrea Cavalli, Anna Minarini, Michela Rosini, Vincenzo Tumiatti, Vincenza Andrisano, Carlo Melchiorre.   

Abstract

Eight monomeric congeners, related to the multitarget lead candidate memoquin, were prepared and evaluated at multiple targets to determine their profile against Alzheimer's disease. 2-4 bind to AChE with similar low nanomolar affinities and function as effective inhibitors of amyloid aggregation. The most potent monovalent ligand 2 also inhibits BACE-1 in vitro and APP metabolism in primary chicken telencephalic neurons.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22054058     DOI: 10.1021/jm200691d

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  6 in total

1.  L-F001, a Multifunction ROCK Inhibitor Prevents 6-OHDA Induced Cell Death Through Activating Akt/GSK-3beta and Nrf2/HO-1 Signaling Pathway in PC12 Cells and Attenuates MPTP-Induced Dopamine Neuron Toxicity in Mice.

Authors:  Liting Luo; Jingkao Chen; Dan Su; Meihui Chen; Bingling Luo; Rongbiao Pi; Lan Wang; Wei Shen; Rikang Wang
Journal:  Neurochem Res       Date:  2017-01-11       Impact factor: 3.996

Review 2.  Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.

Authors:  Michela Rosini; Elena Simoni; Anna Minarini; Carlo Melchiorre
Journal:  Neurochem Res       Date:  2014-02-04       Impact factor: 3.996

3.  Quinone-amino acid conjugates targeting Leishmania amino acid transporters.

Authors:  Federica Prati; Adele Goldman-Pinkovich; Federica Lizzi; Federica Belluti; Roni Koren; Dan Zilberstein; Maria Laura Bolognesi
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 4.  Novel multitarget-directed tacrine derivatives as potential candidates for the treatment of Alzheimer's disease.

Authors:  Wen-Yu Wu; Yu-Chen Dai; Nian-Guang Li; Ze-Xi Dong; Ting Gu; Zhi-Hao Shi; Xin Xue; Yu-Ping Tang; Jin-Ao Duan
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

Review 5.  Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.

Authors:  Marta Campora; Valeria Francesconi; Silvia Schenone; Bruno Tasso; Michele Tonelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-05

6.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.